Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NLRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SAMHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OASL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFIT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOBEC3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HERC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on